GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Numeral Ltd (XMAU:GOLI.N0000) » Definitions » EBITDA Margin %

Numeral (XMAU:GOLI.N0000) EBITDA Margin % : 67.60% (As of Aug. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Numeral EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Numeral's EBITDA for the three months ended in Aug. 2024 was $0.12 Mil. Numeral's Revenue for the three months ended in Aug. 2024 was $0.18 Mil. Therefore, Numeral's EBITDA margin for the quarter that ended in Aug. 2024 was 67.60%.


Numeral EBITDA Margin % Historical Data

The historical data trend for Numeral's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Numeral EBITDA Margin % Chart

Numeral Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Feb18 Feb19 Feb20 Feb21 Feb22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.87 - - - -

Numeral Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 Nov19 Feb20 Aug20 Nov20 Feb21 Aug21 Nov21 Feb22 Aug22 Nov22 May23 Aug23 Nov23 May24 Aug24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 20.00 67.60

Competitive Comparison of Numeral's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Numeral's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Numeral's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Numeral's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Numeral's EBITDA Margin % falls into.



Numeral EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Numeral's EBITDA Margin % for the fiscal year that ended in Feb. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Feb. 2022 )/Revenue (A: Feb. 2022 )
=-0.063/0
= %

Numeral's EBITDA Margin % for the quarter that ended in Aug. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Aug. 2024 )/Revenue (Q: Aug. 2024 )
=0.121/0.179
=67.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Numeral  (XMAU:GOLI.N0000) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Numeral EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Numeral's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Numeral Business Description

Traded in Other Exchanges
Address
142, Mosque Road, Midlands, MUS
Numeral Ltd is a multi-faceted healthcare company offering a comprehensive all-inclusive product range that addresses market needs from pharmaceutical, generic, nutraceutical, medical consumables through to high end sophisticated hospital equipment.

Numeral Headlines

No Headlines